ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,726Medicare Part D Prescriptions Filled, Including Refills

Rank: 169 out of 1206

$490K Total Retail Price of All Prescriptions

Rank: 174 out of 1206

424 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 424 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,316 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 564 475 1 1
FUROSEMIDE 485 447 2 5
OMEPRAZOLE 427 376 3 3
AMLODIPINE BESYLATE 362 331 4 6
LEVOTHYROXINE SODIUM 354 318 5 2
LISINOPRIL 253 229 6 4
METFORMIN HCL 248 225 7 10
ATORVASTATIN CALCIUM 210 198 8 13
HYDROCHLOROTHIAZIDE 193 174 9 11
METOPROLOL TARTRATE 163 151 10 9
GABAPENTIN 156 118 11 18
HYDROCODONE-ACETAMINOPHEN 148 100 S3 12 7
METOPROLOL SUCCINATE 124 107 13 15
DIOVAN 123 122 14 57
POTASSIUM CHLORIDE 122 112 15 12
SERTRALINE HCL 121 109 16 22
CARVEDILOL 120 111 17 32
ALENDRONATE SODIUM 118 104 18 19
FAMOTIDINE 110 89 19 65
TRAMADOL HCL 109 87 20 17
SPIRONOLACTONE 105 85 21 41
TAMSULOSIN HCL 99 84 22 26
WARFARIN SODIUM 99 99 22 8
ISOSORBIDE MONONITRATE ER 97 97 24 40
ATENOLOL 96 91 25 14
LACTULOSE 93 69 26 124
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 91 26 27
NITROFURANTOIN 88 88 28 173
NAMENDA 83 83 29 36
AZITHROMYCIN 81 72 30 46
DONEPEZIL HCL 76 76 31 29
CITALOPRAM HBR 76 75 31 16
DIGOXIN 76 71 31 43
QUETIAPINE FUMARATE 74 53 34 79
ALLOPURINOL 73 68 35 24
PREDNISONE 73 53 35 28
BENAZEPRIL HCL 73 71 35 39
METFORMIN HCL ER 70 68 38 58
BYSTOLIC 65 65 39 109
FLUTICASONE PROPIONATE 65 51 39 42
DILTIAZEM ER 63 63 41 83
FLUOXETINE HCL 63 41 41 52
LANTUS 63 44 41 38
SPIRIVA 62 50 44 66
TRAZODONE HCL 61 35 45 37
NEXIUM 61 60 45 47
CRESTOR 60 60 47 30
CLOPIDOGREL 58 54 48 48
CEPHALEXIN 57 48 49 62
ZOLPIDEM TARTRATE 57 42 49 25
LANTUS SOLOSTAR 54 49 51 85
RANITIDINE HCL 52 44 52 23
ADVAIR DISKUS 51 42 53 55
JANUVIA 50 48 54 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.